Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MRNS | TPST | CSBR | ||
Company | Marinus Pharma CS | Tempest Therapeutics Inc | Champions Oncolog | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.4100 | 3.51 | 4.90 | ||
High | 1.4400 | 3.72 | 5.00 | ||
Low | 1.3900 | 3.44 | 4.74 | ||
Last | 1.4000 | 3.44 | 4.92 | ||
Change | -0.0050 | -0.10 | -0.10 | ||
% Change | -0.36% | -2.82% | -1.99% | ||
Volume | 930,300 | 306,700 | 4,600 | ||
20-Day Average Volume | 4,619,200 | 890,180 | 2,580 | ||
Previous Close | 1.4050 | 3.54 | 5.02 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 4.4735 | 3.71 | 5.00 | ||
20-Day Raw Stochastic | 3.66% | 12.89% | 32.14% | ||
20-Day Relative Strength | 17.81% | 46.40% | 42.03% | ||
Weighted Alpha | -36.97 | -79.40 | -14.60 | ||
Today's Opinion | 88% Sell | 8% Sell | 100% Sell | ||
Previous Opinion | 88% Sell | 8% Sell | 88% Sell | ||
Last Month's Opinion | 40% Buy | 56% Buy | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -5.08% since 04/22/24 | +6.17% since 04/22/24 | -2.77% since 04/19/24 | ||
Low | 1.3700 on 04/25/24 | 3.24 on 04/23/24 | 4.74 on 04/29/24 | ||
High | 1.5600 on 04/23/24 | 3.72 on 04/29/24 | 5.14 on 04/25/24 | ||
1-Month | |||||
%Chg | -84.51% since 03/28/24 | -12.02% since 03/28/24 | +0.41% since 03/28/24 | ||
Low | 1.1100 on 04/16/24 | 3.06 on 04/19/24 | 4.74 on 04/29/24 | ||
High | 9.0700 on 04/01/24 | 6.00 on 04/02/24 | 5.30 on 04/12/24 | ||
3-Month | |||||
%Chg | -86.22% since 01/29/24 | -11.68% since 01/29/24 | -17.86% since 01/29/24 | ||
Low | 1.1100 on 04/16/24 | 3.03 on 03/04/24 | 4.74 on 04/29/24 | ||
High | 10.5000 on 03/01/24 | 6.00 on 04/02/24 | 6.26 on 02/06/24 | ||
6-Month | |||||
%Chg | -78.72% since 10/27/23 | -18.48% since 10/27/23 | -14.43% since 10/27/23 | ||
Low | 1.1100 on 04/16/24 | 2.76 on 11/08/23 | 4.51 on 12/18/23 | ||
High | 11.2600 on 01/08/24 | 6.00 on 04/02/24 | 7.13 on 01/17/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 77,178 | 78,648 | 68,242 | ||
Shares Outstanding, K | 54,931 | 22,217 | 13,594 | ||
Annual Sales | 30,990,000 | 0 | 53,870,000 | ||
Annual Net Income | -141,410,000 | -29,490,000 | -5,340,000 | ||
Last Quarter Sales | 7,190,000 | 0 | 12,020,000 | ||
Last Quarter Net Income | -41,770,000 | -7,490,000 | -2,530,000 | ||
60-Month Beta | 0.91 | -1.76 | 0.39 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.74 on 03/05/24 | -0.34 on 03/19/24 | -0.19 on 03/12/24 | ||
Latest Earnings Date | 05/09/24 | 05/08/24 | 03/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |